Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Amneal Pharmaceuticals, Inc. | amrx-09x30x2018x10qxex322x.htm |
| EX-31.2 - EXHIBIT 31.2 - Amneal Pharmaceuticals, Inc. | amrx-09x30x2018x10qxex312r.htm |
| EX-31.1 - EXHIBIT 31.1 - Amneal Pharmaceuticals, Inc. | amrx-09x30x2018x10qxex311s.htm |
| 10-Q - 10-Q - Amneal Pharmaceuticals, Inc. | amrx-09x30x201810qdoc.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Amneal Pharmaceuticals, Inc. (the “Company”) for the fiscal quarter ended September 30, 2018 (the “Report”), Robert Stewart, President and Chief Executive Officer, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code), that:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
November 7, 2018 | By: | /s/ Robert Stewart |
Robert Stewart | ||
President and Chief Executive Officer (Principal Executive Officer) | ||